Home

OrbiMed Israel GP II, 10% Owner: Damora Therapeutics DMRA Sell · Filed 23/04/12

Trade details

Type
Insider sale
Amount
$62,193.55
Shares · price
34,745 sh · $1.79 a share
Held after
2,500,582 sh
Trade date
23/04/10
Filed
23/04/12
Days to filing
2 days

Sold 1.4% of holdings

Share of holding sold
1.4%

Damora Therapeutics trades, last 26 weeks

What else happened in Damora Therapeutics around then

Filed or reported within 30 days of the trade day · 23/03/11~23/05/10

OrbiMed Israel GP II's recent trades

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $10M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $5.1M

    Filed 09/30

  • OrbiMed Israel GP II

    BuyADARx Pharmaceuticals

    $1M

    Filed 09/30

  • OrbiMed Israel GP II

    SellAdicet Bio

    $263.5K

    Filed 04/09

  • OrbiMed Israel GP II

    SellAdicet Bio

    $204.6K

    Filed 04/09